NCT03708497View on ClinicalTrials.gov

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

May 31, 2020

Study Completion Date

July 1, 2020

Conditions
Postpartum Hemorrhage
Interventions
DRUG

carbetocin

Carbetocin 100 microgram will be applied intravenously in a short infusion over about a minute

DRUG

Tranexamic acid plus misoprostol

1000mg oral TA at the end of the first stage of labor plus 600 mg buccal misoprostol after delivery of the baby. A buccal route, in which the tablets are placed in the cheek for 30 min after which any remnants are swallowed.

DRUG

misoprostol

600 mg buccal misoprostol after delivery of the baby. A buccal route, in which the tablets are placed in the cheek for 30 min after which any remnants are swallowed.

Trial Locations (2)

81528

Aswan University, Aswān

AswanUH, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03708497 - Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery | Biotech Hunter | Biotech Hunter